SMARCB1 mutations, involved in gene expression regulation and also located in close proximity to NF2 on chromosome 22, have also been identified in particularly atypical meningiomas in prior work, but were not identified in our matched tumor pairs [33–35]. The gene discussed is NF2; the disease is neoplasm.